SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Protein Design Labs (PDLI): Stock strong
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
407 58 0 PDLI
Emcee:  Stanley Cowen Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
332Hi Tuck n Board, A little note on the Competition to PDLI's Nuvion: Biggesdr.praveen-8/13/2006
331thestreet.comdr.praveen-8/7/2006
330The positive thing I find with the latest PDLI is it is slimmer and attractive. dr.praveen-8/7/2006
329Royalty revenues lag one quarter behind actual sales. PDL believes Lucentis shokenhott-8/4/2006
328That's the best thing with PDLI... Wall st pulled it down last time coz of tdr.praveen-8/4/2006
327OK, you win. First Albany downgraded the stock this morning. I tend to get thatuck-8/4/2006
326I was cooking while listening to the call, so I only listened with half an ear atuck-8/4/2006
325Good news is PDL dropping drugs/indications early. Bad news PDL is dropping drukenhott-8/4/2006
324I agree with your thoughts. PDLI has not been able to develop much of anything tuck-8/4/2006
323Terlipressin failure is not a big deal Tuck. Already generic in Europe and it isdr.praveen-8/4/2006
322Strangely enough I see that they were going up some 5% AH but I guess a drop is idos-8/4/2006
321Doc, I hear you on the clinical disappointments. But if you watched the after htuck-8/4/2006
320Hi Tuck n All, Looks like PDLI is getting trimmed. I am not commenting on the fdr.praveen-8/3/2006
319PDL BioPharma Announces Second Quarter 2006 Financial Results Thursday August 3,tuck-8/3/2006
318PDL BioPharma Reports Results From Phase 3 Trial of Terlipressin In Type 1 Hepatdr.praveen-8/3/2006
317Saw that article, which is reasonably balanced except it understates the pipe a tuck-8/3/2006
316The picture does n't look so bright but maybe be a few unknown surprises toddr.praveen-8/3/2006
315Me too. Also it's a down day in a very down market for speculative stocks. Doc Bones-8/3/2006
314Is there any space in your boat Tuck :-)? Best...Praveendr.praveen-8/3/2006
313Me too - added a few. I see PDLI as a long runner. idoidos-8/3/2006
312There sure is a lot of fear in front of earnings today. I can't find a whistuck-8/3/2006
311Cross-posting the take from Merrill posted on the Valuation thread: Message 226tuck-7/30/2006
310PDLI gets a DB upgrade and Tysabri returns to market. Combined with a general retuck-7/24/2006
309Info from S&P analyst. About half way down the article. yahoo.businessweekkenhott-7/11/2006
308Actually, I need a clarification here. I -- and many YMB posters -- are going utuck-7/10/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News